Literature DB >> 17184490

Electrophysiological evidence for the interaction of substance P and glutamate on Adelta and C afferent fibre activity in rat hairy skin.

Qi Zhang1, Yan Zhao, Yuan Guo, Dong-Yuan Cao, Yu-Ling Tian, Fan-Rong Yao, Hui-Sheng Wang.   

Abstract

1. The purpose of the present study was to investigate whether there was a cooperative interaction between substance P (SP) and glutamate (GLU) administered subcutaneously on Adelta and C primary afferent fibre activity in dorsal hairy skin of the rat in vivo. The single unit activities of Adelta and C afferent fibres were recorded by isolation of fibre filaments from the dorsal cutaneous nerve branches and the effects of subcutaneous injections of low doses of SP, GLU and SP + GLU on activity were determined. 2. Sub-threshold doses of SP (1 micro mol/L, 10 microL) administered subcutaneously into the dorsal hairy skin had no effect on the afferent discharges of either Adelta or C units. 3. The afferent discharges of 35% (11/31) of Adelta fibres and 33% (6/18) of C fibres were increased by local injection of the submaximal doses of GLU (10 micro mol/L, 10 microL) into the receptive fields. 4. The GLU-induced excitatory response was significantly enhanced by coinjection of subthreshold doses of SP. The mean discharge rates of Adelta fibres and C fibres were increased from 5.84 +/- 1.54 and 5.02 +/- 2.65 impulses/min to 19.91 +/- 4.35 and 17.58 +/- 5.59 impulses/min, respectively, whereas the excitatory proportions of Adelta and C fibres were increased from 35 and 33% to 84 and 83%, respectively. The duration of the excitation for Adelta fibres and C fibres was also significantly increased after coinjection of SP + GLU compared with that observed when either substance was given alone. 5. The present study provides electrophysiological evidence for an interaction between receptors for SP and GLU on the fine fibres activities in rat hairy skin, which may be involved in the mechanisms of hyperalgesia.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17184490     DOI: 10.1111/j.1440-1681.2006.04504.x

Source DB:  PubMed          Journal:  Clin Exp Pharmacol Physiol        ISSN: 0305-1870            Impact factor:   2.557


  6 in total

Review 1.  Glutamate pharmacology and metabolism in peripheral primary afferents: physiological and pathophysiological mechanisms.

Authors:  Kenneth E Miller; E Matthew Hoffman; Mathura Sutharshan; Ruben Schechter
Journal:  Pharmacol Ther       Date:  2011-01-26       Impact factor: 12.310

2.  The role of substance P in acupuncture signal transduction and effects.

Authors:  Yu Fan; Do-Hee Kim; Young Seob Gwak; Danbi Ahn; Yeonhee Ryu; Suchan Chang; Bong Hyo Lee; Kyle B Bills; Scott C Steffensen; Chae Ha Yang; Hee Young Kim
Journal:  Brain Behav Immun       Date:  2020-09-18       Impact factor: 7.217

Review 3.  Understanding propagated sensation along meridians by volume transmission in peripheral tissue.

Authors:  Wei-Bo Zhang; Yan Zhao; Fuxe Kjell
Journal:  Chin J Integr Med       Date:  2013-05-15       Impact factor: 1.978

4.  Induction of Hyperalgesia in Pigs through Blocking Low Hydraulic Resistance Channels and Reduction of the Resistance through Acupuncture: A Mechanism of Action of Acupuncture.

Authors:  Wei-Bo Zhang; Yi-Hui Xu; Yu-Ying Tian; Hong Li; Guang-Jun Wang; Tao Huang; Shu-Yong Jia
Journal:  Evid Based Complement Alternat Med       Date:  2013-08-13       Impact factor: 2.629

Review 5.  Classic and Modern Meridian Studies: A Review of Low Hydraulic Resistance Channels along Meridians and Their Relevance for Therapeutic Effects in Traditional Chinese Medicine.

Authors:  Wei-Bo Zhang; Guang-Jun Wang; Kjell Fuxe
Journal:  Evid Based Complement Alternat Med       Date:  2015-03-02       Impact factor: 2.629

6.  Fructus Viticis methanolic extract attenuates trigeminal hyperalgesia in migraine by regulating injury signal transmission.

Authors:  Wen Wen; Huan Chen; Kun Fu; Jiangping Wei; Lixia Qin; Ting Pan; Shijun Xu
Journal:  Exp Ther Med       Date:  2019-11-15       Impact factor: 2.447

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.